Karen Coffman

Title: Karen Coffman: Innovator in Antibody Development

Introduction

Karen Coffman is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting vascular endothelial growth factor (VEGF) and angiopoietin (ANG). With a total of 4 patents to her name, her work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Karen's latest patents include groundbreaking inventions such as "Nucleic acids encoding anti-VEGF-A antibodies and uses thereof." This invention relates to antibodies that exhibit activity against VEGF, along with methods for their production and application. Another notable patent is "Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses thereof," which focuses on bispecific antibodies that target both VEGF and ANG, providing innovative methods for their creation and use.

Career Highlights

Karen Coffman is currently associated with Medimmune Limited, where she continues to advance her research in antibody development. Her expertise in this area has positioned her as a key figure in the biotechnology sector, contributing to the development of novel therapeutic solutions.

Collaborations

Some of her notable coworkers include Ching Ching Leow and Nazzareno Dimasi, who collaborate with her on various projects within the company.

Conclusion

Karen Coffman's innovative work in the field of antibody development showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic approaches that could benefit many patients in the future.